Rice University study finds possible clues to epilepsy, autism

December 09, 2008

Rice University researchers have found a potential clue to the roots of epilepsy, autism, schizophrenia and other neurological disorders.

While studying the peripheral nerves of the Drosophila, aka the fruit fly, Rice doctoral student Eric Howlett discovered an unanticipated connection between glutamate - an amino acid and neurotransmitter in much of the food we eat - and phosphoinositide 3-kinase (PI3K), an enzyme that, Howlett found, regulates the activity of neurons.

Howlett and his colleagues, graduate student Curtis Chun-Jen Lin, research technician William Lavery and Michael Stern, a professor of biochemistry and cell biology, discovered that negative feedback mediated by PI3K regulates the excitability of neurons, an issue in a number of ailments that include neurofibromatosis, and that a mutation in a glutamate receptor gene common to both the fruit fly and humans has the ability to disrupt that regulatory mechanism.

Howlett found the Drosophila's metabotropic glutamate receptor (DmGluRA) gene, when mutated, increased the excitability of the neuron by preventing PI3K from doing its job.

Published online by the Public Library of Science Genetics, the study is the culmination of four years of work that built upon research by Marie-Laure Parmentier and her team at the University of Montpelier, France, to connect glutamate to regulatory functions in the fruit fly.

"As science often goes, we didn't set out with this hypothesis," said Howlett, who began the project on funding obtained by Stern from the Department of Defense to study neurofibromatosis. "This all came about as a control for a completely different experiment, and we said, 'Wow, this is some interesting stuff.'"

What he saw was that the overexpression of PI3K in motor neurons had a dramatic effect. "I noticed under the scope that these nerves were really big, and electrophysiologically, they were really slow. That wasn't what I expected, and it set me on a path of trying to find out what was going on."

Howlett's breakthrough was identifying the negative feedback loop that acts to maintain neuronal excitability at normal levels. "What we found was that glutamate, which is released due to neuronal activity, feeds back onto metabotropic glutamate receptors on the same neurons that released it in the first place. This leads to the activation of PI3K and ultimately to the dampening of the amount of glutamate that is released." Without that regulation, he said, things inside the cell can go terribly wrong.

"He put his heart and soul into this," said Stern of Howlett's exploration of the neuronal chain. "He was working on PI3K because that has a key role in neurofibromatosis. The Department of Defense is very interested in how PI3K is regulated in the nervous system because of its role in tumor formation."

Discovering the negative feedback loop that keeps neurons stable was key, said Stern, but not the end of the investigation. "We know that glutamate activates mGluR and PI3K, but we don't know how," he said. "There are almost certainly a number of intermediates that remain to be identified, and we have several candidates we're looking into.

"We're finding a mechanistic link among these molecules that hadn't been previously appreciated," Stern said.

"Obviously the next step would be to test whether these same molecules are playing similar roles in mammalian neurons," said Howlett, who will leave Rice in the spring to pursue postdoctoral cancer research at Virginia Commonwealth University. A native Houstonian, he earned his bachelor's in biology at the University of Houston-Clear Lake.

Howlett said mGluRs had already been targeted in possible treatments for schizophrenia, epilepsy and other "excitability" diseases, so it's not a stretch to think his research could lead to even more strategies in treating neurological ailments.

"Actually, all of the molecules involved in our model have been implicated in one way or another with neurological diseases, but no one has been able to link them together into a coherent explanation of the diseases," he said. "Our model provides a novel framework that could really go a long way toward doing that."

The paper can be found at: www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1000277.

Rice University

---

---

	Thriving With Neurofibromatosis by Kristi Hopkins (Author) 1 in 3000 people are born with Neurofibromatosis. It affects all of us in different ways. For some, Neurofibromatosis is as clear as the tumors on their face. For others, it hides beneath the surface, creating tumors that destroy hearing, vision, and more. Many of us are misdiagnosed, misunderstood, and often simply missed by a world of medicine that doesn't have a full grasp on all teh effects of NF. Stereotyped, ignored, or shunned by a world who thinks we either have the Elephant Man's disease, common migraines, or a few too many moles and birthmarks. In a society that values beauty so highly, NF'ers often choose to hide from others, and end up hiding from themselves. In 2007, Kristi chose to stop hiding, and start Thriving, as NF became a bigger part of my life than...
	Neurofibromatosis: A Handbook for Patients, Families and Health Care Professionals by Bruce R. Korf (Editor), Allen E. Rubenstein (Editor) Here is the state-of-the-art on recognizing, managing and living with neurofibromatosis (NF) for patients, families, and health care professionals. From new genetic and diagnostic advances, to associated cardiovascular and endocrine abnormalities, to the significant psychosocial impact of NF, the book is packed with clear, practical guidance for understanding and living with this disability.Special features:A complete diagnostic guide to help you recognize NF-related symptoms--with a timeline for when they might appear New treatment options for NF, including pain control Coverage of the newly discovered form of NF, schwannomatosis Personal perspectives from NF patients and their families Glossary that defines medical terminologyWith the great diagnostic and treatment...
	Neurofibromatosis: Causes, Tests and Treatment Options by Anthony S Michaels MA (Author), Jennifer Grange MD (Editor) Neurofibromatosis is a disease that disturbs the proper growth of the cells of your nervous system. It is genetic, which means that you may suffer from it because one or both of your parents had this disease. If you get affected with neurofibromatosis, you have an increased risk of being affected with other kinds of tumors related to nervous system, such as spinal cord tumors. Cancer is caused by neurofibromatosis tumors in very rare cases. So far, there is no definite cure for neurofibromatosis. However, researchers and clinicians have discovered new ways to treat patients with specific neurofibromatosis-related problems.
	Kirsty's Story: Living with Neurofibromatosis and Scoliosis by Kirsty Ashton (Author)
	The Man Who Murdered Himself: A Short Story Kyle Ameus Waterbey is afflicted with a hideous illness. He would do anything to be rid of it. Anything. Kyle suffers from neurofibromatosis, a crippling disease most famously associated with the Elephant Man.  When a shady medical practitioner offers Kyle a chance to cast off his deformed appearance forever, he accepts without a second thought.  But does Kyle truly understand what this new treatment will cost him? This story has won a Phobos Award and the Vera Hinckley Mayhew Award.  It is also included in the collection Dead Men Don't Cry: 11 Stories by Nancy Fulda. About 8 pages or 3,000 words.
	I'm Not Sick, Just A Bit Unwell by Kia Kaha Press Yvonne Foong was just sixteen when she was diagnosed with neurofibromatosis, a genetic illness with no cure. That discovery propelled her into the fight of her life, and she embarked on an odyssey to America to treat the tumours raging within her. Stark and revealing, this memoir peels back the curtains on her experience and reveals exactly what it means to endure the unendurable. It's an inspiring journey which captivated a nation, winning Yvonne Foong the title of Most Outstanding Youth at the 2005 Dream Malaysia Awards. Straddling borders and cultures, this is a story of friendship, faith and hope. A story you won’t soon forget. *** EXCERPT I was seated comfortably in the doctor’s office that day. The other...
	Living with Genetic Disorder: The Impact of Neurofibromatosis 1 by Joan Ablon (Author) A description of the social, educational, and economic impact of living with a neurological genetic disorder, neurofibromatosis 1. The many unpredictable and potentially stigmatizing possible symptoms of NF1, which range from physical disfigurement to severe learning disorders, may have serious consequences in every aspect of daily life. NF1 was for many years wrongly diagnosed as the Elephant Man's Disease.Ablon examines the psychosocial costs of this misdiagnosis and the ways in which stage, screen, and television parlayed The Elephant Man into the personification of the grimmist extreme of ugliness. This portrayal engendered fear and anxiety for affected persons and their families and also had an impact on the scientific and medical communities. Ablon analyzes the factors that affect...
	Neurofibromatosis: Trusting God in the midst of NF by Renee B Wilson (Author)
	Neurofibromatosis: Phenotype, Natural History, and Pathogenesis (Johns Hopkins Series in Contemporary Medicine and Public Health) by Dr. J. M. Friedman MD PhD (Editor), Dr. David H. Gutmann MD-PhD (Editor), Dr. Mia MacCollin MD (Editor), Dr. Vincent M. Riccardi MD (Editor) Now in its third edition, Neurofibromatosis has been extensively rewritten by a group of leading neurofibromatosis (NF) researchers. It summarizes the current state of knowledge and details significant advances in the basic science and clinical care of patients with NF1 and NF2. Areas of particular emphasis include aspects of natural history, variability, pathology, molecular biology, and cellular biology that give a deeper understanding of the mechanisms responsible for these diseases. The book is a definitive, comprehensive review of the history, heterogeneity, pathogenesis, genetics, and management of NF1 and NF2.Praise for the second edition:"For anyone embarking on scientific and clinical research of neurofibromatosis, the Riccardi book, particularly in view of its exhaustive...
	Advances in Neurofibromatosis Research (Neurology-Laboratory and Clinical Research Developments: Genetics-Research and Issues) by Karin Soares Goncalves Cunha (Editor), Mauro Geller (Editor) This is a practical and objective book that provides an updated and comprehensive overview, offering insight into the research advances in neurofibromatosis. This book represents a reference source for researchers, healthcare professionals from various fields, as well as students, about different aspects of neurofibromatosis. In addition, this book useful guidance to researchers and health professionals seeking to contribute to longevity and improved quality of life for patients and their families.